Lung Cancer
Oncology

Lung Cancer

China sees 828,000 new cases and 715,000 deaths annually. 80% are non-small cell lung cancer (NSCLC), with 75% diagnosed in middle to late stages. Precise companion diagnostics are critical for treatment selection.

Digital PCR Solution

Multigene Companion Diagnosis

Aperbio's droplet chip digital PCR enables precise detection of key driver mutations to guide targeted therapy decisions.

  • EGFR mutation (exon 18/19/20/21) — most common driver in Asian NSCLC
  • KRAS G12/G13 mutations — resistance marker for EGFR therapy
  • BRAF V600E — targetable in ~2% of NSCLC
  • NRAS mutations — resistance monitoring
  • ALK, HER2, NTRK, ROS1 fusion detection
Digital PCR System for Lung Cancer
Workflow

Step-by-Step Process

Nucleic Acid Extraction

1. Extraction

Automated nucleic acid extraction from liquid biopsy (ctDNA) or tissue samples.

Loading

2. Loading

Automated droplet chip loading with the Naica System — no manual partitioning needed.

Amplification

3. Amplification & Analysis

Crystal Digital PCRâ„¢ with 6-color multiplexing and absolute quantification results.

Ready to Learn More?

Talk to our clinical application specialists about implementing lung cancer companion diagnostics in your lab.

Request a Demo